Pleural mesothelioma: combined modality treatments

被引:105
作者
Giaccone, G [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Div Med Oncol, Amsterdam, Netherlands
关键词
D O I
10.1093/annonc/mdf663
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:217 / 225
页数:9
相关论文
共 125 条
[61]  
LEGHA SS, 1977, CANCER TREAT REV, V4, P13, DOI 10.1016/S0305-7372(77)80016-9
[62]  
LERNER HJ, 1983, CANCER, V52, P1981, DOI 10.1002/1097-0142(19831201)52:11<1981::AID-CNCR2820521102>3.0.CO
[63]  
2-P
[64]   Effect of hemithorax irradiation alone or combined with doxorubicin and cyclophosphamide in 47 pleural mesotheliomas: A nonrandomized phase II study [J].
Linden, CJ ;
Mercke, C ;
Albrechtsson, U ;
Johansson, L ;
Ewers, SB .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (12) :2565-2572
[65]  
MAASILTA P, 1991, EUR RESPIR J, V4, P952
[66]   EPIRUBICIN IN THE TREATMENT OF MALIGNANT MESOTHELIOMA - A PHASE-II COOPERATIVE STUDY [J].
MAGRI, MD ;
VERONESI, A ;
FOLADORE, S ;
DEGIOVANNI, D ;
SERRA, C ;
CRISMANCICH, F ;
TUVERI, G ;
NICOTRA, M ;
TOMMASI, M ;
MORASSUT, S ;
CARBONE, A ;
GRANDI, G ;
MONFARDINI, S ;
BIANCHI, C .
TUMORI, 1991, 77 (01) :49-51
[67]   TREATMENT OF MALIGNANT MESOTHELIOMA WITH EPIRUBICIN AND IFOSFAMIDE - A PHASE-II COOPERATIVE STUDY [J].
MAGRI, MD ;
FOLADORE, S ;
VERONESI, A ;
SERRA, C ;
NICOTRA, M ;
TOMMASI, M ;
GRANDI, G ;
MONFARDINI, S ;
BIANCHI, C .
ANNALS OF ONCOLOGY, 1992, 3 (03) :237-238
[68]  
MARTENSSON G, 1989, CANCER CHEMOTH PHARM, V24, P133
[69]   EPIRUBICIN IN MALIGNANT MESOTHELIOMA - A PHASE-II STUDY OF THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER LUNG-CANCER COOPERATIVE GROUP [J].
MATTSON, K ;
GIACCONE, G ;
KIRKPATRICK, A ;
EVRARD, D ;
TAMMILEHTO, L ;
VANBREUKELEN, FJM ;
PLANTEYDT, HT ;
VANZANDWIJK, N .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (05) :824-828
[70]  
MBIDDE EK, 1986, CANCER CHEMOTH PHARM, V18, P284